TST-008

N/A

Report date: 2026/01/05 17:17:46
First In Class

Base Information

Drug NameTST-008
Drug Alias NameTST 008TST-008
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionMannan-binding lectin serine protease 2 inhibitorsAnti-B-cell-activating factor/B lymphocyte stimulator
TargetsMannan-binding lectin serine protease 2B-cell-activating factor/B lymphocyte stimulator
Therapy Area/IndicationsGlomerulonephritis, IGAKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTranscenta Holding Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTranscenta Holding Ltd
Inactive CompaniesN/A
Active IndicationsGlomerulonephritis, IGAKidney Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A